Hemant Surgical Industries logo

Hemant Surgical Industries

543916 BSE
₹572.55 5.75 (1.01%)
Market Cap
₹832 Cr

Hemant Surgical Industries (HSIL) share price was ₹572.55 at the 28 Oct 2026 close; market capitalisation ₹832 Cr; sector Healthcare. The share price rose 103.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹167 Cr, against ₹58 Cr a year earlier and net profit was ₹13 Cr, against ₹5 Cr a year earlier (compared with Mar 2025). Promoters held 52.83% of Hemant Surgical Industries in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 56/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹572.55 +291.65 +103.83% 1Y

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare
Market Cap
₹832 Cr
EBITDA
₹29.10 Cr
Return on Equity
13.22%
Debt to Equity
0.36
Book Value
₹107.89
EPS (TTM)
—
52W High
₹679.00
52W Low
₹215.00

Price-based figures as of 28 Oct 2026, 16:30 IST · TTM

Peer Comparison

Healthcare › Medical Equipment › Medical Equipment & Supplies

Poly Medicure
₹1,476.0047.4814,961 Cr4.820.24%10.18%13.33%2,115 Cr313 Cr
Fischer Medical Ventures
₹26.6670.161,745 Cr3.810.20%8.11%12.69%373 Cr24 Cr
Tarsons Products
₹304.60145.741,621 Cr2.550.66%2.26%4.82%468 Cr11 Cr
Q-Line Biotech
₹544.4525.801,270 Cr2.600.00%22.63%26.37%201 Cr34 Cr
Laxmi Dental
₹181.3932.33998 Cr4.100.00%10.83%11.51%289 Cr31 Cr
Hemant Surgical Industries (this company)
₹572.55—832 Cr5.310.00%13.22%19.52%——
Median 6 companies₹424.5347.481,445 Cr3.960.10%10.51%13.01%373 Cr31 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
56 Good
Overall score
Data confidence 84/100

Category scores

Quality Strong 71
Returns, margins, earnings quality 22%
Valuation Poor 22
Cheap vs sector & own history 24%
Growth Strong 99
Sales & profit trajectory 9%
Financial Health Average 46
Solvency, leverage, coverage 9%
Momentum Strong 94
Trend strength, vol-adjusted 12%
Ownership Weak 40
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has delivered good profit growth of 65.6% CAGR over last 5 years
  • Company's working capital requirements have reduced from 45.5 days to 24.0 days

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 83.7 to 106 days.
  • Promoter holding has decreased over last 3 years: -20.7%

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

BearishNeutralBullish

Bullish

Bearish
6
Neutral
6
Bullish
7

Moving Averages

BearishNeutralBullish

Bullish

Bearish
4
Neutral
0
Bullish
6

Growth Rate

Revenue Growth
113% higher than 3Y

change over 1 year

Net Income Growth
128% higher than 3Y

change over 1 year

Cash Flow Change
-792%

change over 1 year

EBITDA Margin Change
-3.09%

change over 1 year Operating margin 9% · Mar 2026

Quarterly Results

Particulars Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
51
58
48
58
49
58
64
167
Expenses
47
52
44
51
45
52
57
151
Operating Profit
4
6
3
7
4
6
8
16
OPM %
8%
11%
7%
13%
7%
10%
12%
9%
Other Income
1
1
3
2
2
3
2
3
Interest
1
1
1
0
1
1
2
2
Depreciation
0
0
1
1
1
1
1
1
PBT
4
6
5
8
4
6
7
16
Tax %
36%
18%
17%
27%
29%
18%
25%
22%
Net Profit
2
5
4
6
3
5
5
13
EPS (₹)
2.89
6.93
3.75
5.63
3.05
4.74
4.15
9.84
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
51
56
56
60
101
109
106
107
231
Expenses
48
53
53
57
95
98
95
97
208
Operating Profit
2
3
3
3
6
11
10
9
23
OPM %
4.9%
4.8%
4.7%
5%
6%
10%
10%
9%
10%
Other Income
0
0
0
1
2
2
4
5
6
Interest
1
1
2
2
2
2
1
2
4
Depreciation
0
1
0
1
1
1
1
1
2
PBT
1
1
1
1
6
10
13
11
24
Tax %
10%
8%
41%
9%
25%
24%
23%
23%
23%
Net Profit
1
1
0
1
5
8
10
8
18
EPS (₹)
3.13
3.77
1.67
4.53
15.37
9.95
9.39
7.79
13.98
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
2
2
2
8
10
10
13
Reserves
5
6
5
8
11
16
44
53
124
Borrowings
9
11
14
14
10
7
7
31
50
Other Liabilities
12
14
23
15
32
34
38
54
87
Total Liabilities
28
33
44
40
54
65
100
148
274
Fixed Assets
7
8
10
11
12
13
18
40
53
CWIP
0
0
0
0
0
0
0
12
0
Investments
0
0
1
0
1
0
5
0
0
Other Assets
21
25
33
29
42
51
77
96
220
Total Assets
28
33
44
40
54
65
100
148
274
Figures in ₹ Crores

Cash Flow

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
2
-4
12
6
-4
5
-32
Investing
0
0
-2
-2
0
-3
-12
-30
-10
Financing
0
0
2
5
-8
-1
21
22
76
Net Cash Flow
0
0
2
-2
4
3
5
-4
34
Free Cash Flow
0
0
-1
-7
12
2
-13
-31
-37
CFO/EBITDA
0
0
68
-127
197
84
-9
78
-118
Figures in ₹ Crores

Ratios

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
35
36
35
26
56
58
75
70
106
Inventory Days
64
73
125
113
57
67
99
206
120
Days Payable
102
97
143
89
92
110
116
188
146
Cash Conversion Cycle
-3
12
17
51
21
15
58
87
80
Working Capital Days
12
23
-28
41
-19
2
52
61
24
ROCE %
—
15%
12%
14%
32%
45%
30%
16%
19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Hemant Surgical Industries insights

55 extracted metrics + investor summaries across FY18–FY26.

Shareholding Pattern

Others3.99%Promot.52.83%DIIs19.94%Public23.24%As ofSep 2026

Documents

Frequently Asked Questions about Hemant Surgical Industries

What does Hemant Surgical Industries Ltd do?
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
Where is Hemant Surgical Industries Ltd (HSIL) listed?
Hemant Surgical Industries Ltd trades under code 543916 on the BSE.
Which sector does Hemant Surgical Industries Ltd belong to?
Hemant Surgical Industries Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a market capitalisation of ₹832.32 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Hemant Surgical Industries Ltd?
Over the last 52 weeks Hemant Surgical Industries Ltd has traded between ₹215 and ₹679 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd reported a return on equity of 13.22%. Its debt-to-equity ratio is 0.36.

Company Information

Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]

Website hemantsurgical.com
Listed 2023-06-05
Face Value ₹ 10
Shares Outstanding 1,45,37,037

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543916.md for Hemant Surgical Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month